Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Puma Biotechnology (PBYI) Other Gross PP&E Adjustments (2017 - 2025)

Puma Biotechnology's Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$1.6 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 158.25% year-over-year to -$1.6 million; the TTM value through Dec 2025 reached -$1.6 million, down 158.25%, while the annual FY2025 figure was -$1.6 million, 158.25% down from the prior year.
  • Other Gross PP&E Adjustments reached -$1.6 million in Q4 2025 per PBYI's latest filing, up from -$1.7 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.7 million in Q4 2024 to a low of -$12.1 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$4.1 million, with a median of -$3.1 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 420.21% in 2024, then crashed 317.79% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$6.1 million in 2021, then increased by 25.57% to -$4.5 million in 2022, then surged by 81.29% to -$846000.0 in 2023, then soared by 420.21% to $2.7 million in 2024, then plummeted by 158.25% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Other Gross PP&E Adjustments are -$1.6 million (Q4 2025), -$1.7 million (Q3 2025), and $736000.0 (Q2 2025).